The Wayne, Penn.-based company’s device integrates with the AsthmaMD smartphone app, which digitally logs peak flow meter readings, symptoms and medication use. The app also helps patients share the collected data with their physicians using the cloud-based MyAsthmaMD Physician Portal.
“Teleflex is committed to connecting clinicians and patients with technology that improves patient outcomes,” president of Teleflex’s respiratory division, James Ferguson said in prepared remarks. “Asthma is the 3rd-leading cause of hospitalization in children and Teleflex is proud to now offer the AsthmaMD Peak Flow Meter to help these and other asthma patients.”
Teleflex paid 30.2¢ apiece for the roughly 28.5 million shares in Pyng, which makes intraosseous infusion technology, pelvic stabilization & emergency tourniquet devices.